• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉腔内血管成形术围手术期胃石症合并不完全性肠梗阻1例报告

Gastrolithiasis with incomplete intestinal obstruction in the perioperative period of percutaneous transluminal coronary intervention: one case report.

作者信息

Sun Haijiao, Gao Chang, Wei Xuhui

机构信息

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

出版信息

Ann Palliat Med. 2020 Nov;9(6):4389-4393. doi: 10.21037/apm-20-467. Epub 2020 Jun 15.

DOI:10.21037/apm-20-467
PMID:32576009
Abstract

Gastrolithiasis is one of the uncommon clinical diseases with low incidence and its clinical manifestations are not typical. It is easy to be ignored when combined with other medical diseases. In this paper we present a case of gastrolithiasis just after percutaneous transluminal coronary intervention (PCI), the patient suffered from unexplained persistent abdominal distention and pain with gastric retention, nausea and vomiting. The patient's symptoms were similar to dyspepsia in the first 4 days, so gastrolithiasis wasn't considered, and it became worse with an incomplete intestinal obstruction on the 5th day (see the timeline for details). After a series of examinations, the patient was diagnosed as gastrolithiasis, then after endoscopic removal while taking dual antiplatelet therapy (DAPT), her condition rapidly improved and discharged after a week without any adverse events. Through following-up, the patient is very careful of diet and her digestive system symptoms seldom appear so far. So gastroscopy may be safe in the perioperative period of PCI with no history of upper gastrointestinal bleeding (UGIB). We suggest that the possibility of gastrolithiasis should be considered to avoid adverse consequences when patients have persistent abdominal distention and abdominal pain with gastric retention, which is difficult to determine the causes.

摘要

胃石症是一种临床少见、发病率低且临床表现不典型的疾病。当它与其他内科疾病合并存在时,很容易被忽视。本文报道1例经皮冠状动脉腔内血管成形术(PCI)术后并发胃石症的病例,患者术后出现不明原因的持续性腹胀、腹痛伴胃潴留、恶心、呕吐。患者最初4天的症状类似消化不良,因此未考虑胃石症,第5天出现不完全性肠梗阻且病情加重(详见时间线)。经过一系列检查,患者被诊断为胃石症,在内镜下取出胃石的同时给予双联抗血小板治疗(DAPT),患者病情迅速改善,1周后出院,无任何不良事件发生。通过随访发现,患者对饮食非常注意,至今消化系统症状很少出现。因此,对于无消化道出血病史的PCI围手术期患者,胃镜检查可能是安全的。我们建议,当患者出现难以明确病因的持续性腹胀、腹痛伴胃潴留时,应考虑胃石症的可能,以避免不良后果。

相似文献

1
Gastrolithiasis with incomplete intestinal obstruction in the perioperative period of percutaneous transluminal coronary intervention: one case report.经皮冠状动脉腔内血管成形术围手术期胃石症合并不完全性肠梗阻1例报告
Ann Palliat Med. 2020 Nov;9(6):4389-4393. doi: 10.21037/apm-20-467. Epub 2020 Jun 15.
2
[The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].[中国南方经皮冠状动脉介入治疗后接受双联抗血小板治疗患者上消化道出血的发生率、临床特征及危险因素]
Zhonghua Nei Ke Za Zhi. 2016 Jun;55(6):445-50. doi: 10.3760/cma.j.issn.0578-1426.2016.06.009.
3
[Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].经皮冠状动脉介入治疗术后患者双联抗血小板治疗联合质子泵抑制剂安全性和有效性的Meta分析
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Feb 24;47(2):129-140. doi: 10.3760/cma.j.issn.0253-3758.2019.02.010.
4
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).接受经皮冠状动脉介入治疗的慢性肾脏病患者和非慢性肾脏病患者中断双联抗血小板治疗的发生率、模式和影响:PARIS 登记研究(支架置入患者抗血小板治疗方案不依从模式)的结果。
Circ Cardiovasc Interv. 2018 Mar;11(3):e006144. doi: 10.1161/CIRCINTERVENTIONS.117.006144.
5
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.基线贫血对经皮冠状动脉介入治疗后双联抗血小板治疗停药和不良事件风险的影响。
Circ Cardiovasc Interv. 2019 Apr;12(4):e007133. doi: 10.1161/CIRCINTERVENTIONS.118.007133.
6
Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial.新型血小板聚集功能检测指导下的稳定型冠状动脉疾病行经皮冠状动脉介入治疗患者的个体化抗血小板治疗:一项随机对照临床试验。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):211-221. doi: 10.1093/ehjcvp/pvz059.
7
Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary intervention.经皮冠状动脉介入治疗后出院后胃肠道出血的预测因素和后果。
Cardiovasc Ther. 2018 Oct;36(5):e12440. doi: 10.1111/1755-5922.12440. Epub 2018 Aug 14.
8
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.接受经皮冠状动脉介入治疗患者使用双联抗血小板治疗及其预后:ROCKET AF试验
JACC Cardiovasc Interv. 2016 Aug 22;9(16):1694-702. doi: 10.1016/j.jcin.2016.05.039.
9
A case of gastrolithiasis produced by a 5-day diet.一例由5天特定饮食导致的胃石症病例。
DEN Open. 2024 Sep 16;5(1):e70012. doi: 10.1002/deo2.70012. eCollection 2025 Apr.
10
Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后接受心脏或非心脏手术患者的静脉抗血小板治疗桥接
Cardiovasc Revasc Med. 2019 Sep;20(9):805-811. doi: 10.1016/j.carrev.2018.11.018. Epub 2018 Nov 22.